PBE
Invesco Biotechnology & Genome ETF·ARCA
--
--(--)
--
--(--)
Invesco Biotechnology & Genome ETF Fundamentals
Assets Under Management
238.12MUSD
Fund Flows (1Y)
-34.66MUSD
Dividend Yield (TTM)
1.44%
Discount/Premium to NAV
0.07%
Shares Outstanding
3.11M
Expense Ratio
0.58%
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -6.71% | -8.84% | -6.44% | +14.80% | +27.11% | +2.59% |
NAV Total Return | -6.97% | -8.82% | -6.94% | +15.62% | +26.91% | +8.85% |
Ratings
Aime Ratings
No data is currently available
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
100%
Category
Ratio
North America
100.00%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
UTHR
United Therapeutics
5.94%
ILMN
Illumina
5.44%
REGN
Regeneron
5.15%
BIIB
Biogen
5.08%
GILD
Gilead Sciences
5.05%
ALNY
Alnylam Pharmaceuticals
4.97%
AMGN
Amgen
4.93%
INCY
Incyte
4.83%
BCRX
BioCryst Pharmaceuticals
3.79%
PTGX
Protagonist
3.32%
Top 10 Weight 48.5%
33 Total Holdings
Is SPY better than PBE?
Dividends
Dividend Payout History
Ex-Div Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2026-03-23 | 2026-03-23 | 2026-03-27 | 0.082 |
| 2025-12-22 | 2025-12-22 | 2025-12-26 | 0.420 |
| 2025-09-22 | 2025-09-22 | 2025-09-26 | 0.234 |
| 2025-06-23 | 2025-06-23 | 2025-06-27 | 0.130 |
| 2025-03-24 | 2025-03-24 | 2025-03-28 | 0.034 |
| 2024-06-24 | 2024-06-24 | 2024-06-28 | 0.008 |
| 2024-03-18 | 2024-03-19 | 2024-03-22 | 0.024 |
Show more
How Much Does PBE Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy PBE?
Fund Flows
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
